Newsletter | June 5, 2024

06.05.24 -- Critical Steps To Optimize Viral Vector Manufacturing With CDMOs

SPONSOR

A Full-Service Outsourcing Partner with 97% Customer Retention

inSeption Group offers a full-service solution designed to disrupt the current outsourcing paradigm, resurrecting a common-sense approach to rebuild business trust and confidence in a client’s selected vendor. Primarily focused on oncology, hematology, neurodegenerative disorders, and rare/orphan disease indications, with a specialization in cell and gene therapy, inSeption has been a solution for its’ clients who have experienced the progressive degradation of today’s outsourcing options. Contact them.

INDUSTRY INSIGHTS

Critical Steps To Optimize Viral Vector Manufacturing With CDMOs

To develop a fruitful viral vector manufacturing process and a mutually beneficial relationship between sponsor and CDMO, learn to balance cost, quality, and timeline via transparent communication.

Keys To A Successful cGMP Manufacturing Operation Delivering CGTs

Uncover the secrets behind successes in commercializing and producing commercial cell and gene therapies, including establishing standards of everyday, manufacturing operational excellence.

Functional Testing Summary Of Daikyo Crystal Zenith Nested Vials

This technical report delves into how Daikyo Crystal Zenith nested vials excel in functional testing, meeting stringent standards and ensuring performance in ultra-cold conditions.

Best Practices To Adapt And Improve Quality Control Programs For CGTs

Cell and gene therapies require adaptive and advanced assays for characterization and safety assessments; in many instances, the assays historically used for biologics must diversify to accommodate them.

How Our Requalification Process Maintains Material Integrity

Review a breakdown of how to requalify every shipper for its impending transit and ensure your therapy material maintains integrity and safety during transportation.

FROM THE EDITOR

ISCT 2024 With Dr. Bruce Levine

Here are highlights, quotes, and more from Episode 76 of Cell & Gene: The Podcast featuring Dr. Bruce Levine.

SPONSOR

With additional cell therapy approvals on the horizon, a diverse array of products and platforms are needed to ensure safety and efficacy in manufacturing, increase speed to market, and decrease overall COGS. Join Cell & Gene Live for a digital discussion on the next generation of platforms and innovative technologies. Registration is free thanks to the support of Invetech.

SOLUTIONS

Talk To Our Experts About Clinical And Regulatory Strategy

A CGT CDMO With Devotion

Connect With Cell & Gene: